Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer

Prostaglandins and Other Lipid Mediators

Volumn 116-117, Issue , 2015, Pages 99-103

  Kochel, Tyler J ^a   Fulton, Amy M ^b,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

15 Hydroxyprostaglandin dehydrogenase; Cyclooxygenase 2; Multidrug resistance associated protein 4; Prostaglandin E2; Prostaglandin transporter

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; AROMATIC HYDROCARBON RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; LIPOXIN A; MONOCARBOXYLATE TRANSPORTER 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN TRANSPORTER; PROTEIN KINASE B; STAT3 PROTEIN; TRANSCRIPTION FACTOR NRF2; TRICHOSTATIN A; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; ABCC4 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; SLCO2A1 PROTEIN, HUMAN; TUMOR PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER THERAPY; CARDIOTOXICITY; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CELLS; DRUG CLEARANCE; DRUG RESISTANCE; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNE EVASION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; ONCOGENE C MYB; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; DINOPROSTONE; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; ORGANIC ANION TRANSPORTERS;

EID: 84925990056     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2014.11.003     Document Type: Review

References (65)

1. A. Jemal, R. Siegel, and J. Xu Cancer Statistics, 2010 CA: A Cancer Journal for Clinicians 60 2010 277 300 10.3322/caac.20073
2. N. Howlader, A. Noone, and M. Krapcho SEER Cancer Statistics Review, 1975-2011. 2014 http://seer.cancer.gov/csr/1975-2011. Accessed June 30
3. A. Greenhough, H.J.M. Smartt, and A.E. Moore The COX-2/PGE pathway: key roles in the hallmarks of cancer and adaptation to the tumor microenvironment Carcinogenesis 30 2009 377 386 10.1093/carcin/bgp014
4. D.G. Menter, and R.N. Dubois Prostaglandins in cancer cell adhesion, migration, and invasion Int J Cell Biol 2012 2012 723419 10.1155/2012/723419
5. J.A. Glover, C.M. Hughes, and M.M. Cantwell A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer Br J Cancer 105 2011 13 17 10.1038/bjc.2011.204
6. N. Kundu, X. Ma, and D. Holt Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function Breast Cancer Res Treat 117 2009 235 242 10.1007/s10549-008-0180-5
7. X. Ma, N. Kundu, and S. Rifat Receptor EP4 Antagonism Inhibits Breast Cancer Metastasis Cancer Research 66 2006 2923 2927 10.1158/0008-5472.CAN-05-4348
8. M. Dohadwala, R.K. Batra, and J. Luo Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion J Biol Chem 277 2002 50828 50833 10.1074/jbc.M210707200
9. S. Liu, C. Ginestier, and S.J. Ou Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks Cancer Res 71 2011 614 624 10.1158/0008-5472.CAN-10-0538
10. H.-J. Li, F. Reinhardt, and H.R. Herschman Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling Cancer Discov 2 2012 840 855 10.1158/2159-8290.CD-12-0101
11. W. Goessling, T.E. North, and S. Loewer Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration Cell 136 2009 1136 1147 10.1016/j.cell.2009.01.015
12. N. Kundu, X. Ma, and T. Kochel receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties Breast Cancer Res Treat 143 2013 19 31 10.1007/s10549-013-2779-4
13. R. Ganesh, D.J.B. Marks, and K. Sales Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells World J Surg Oncol 10 2012 200 10.1186/1477-7819-10-200
14. E. Half, X.M. Tang, and K. Gwyn Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ Cancer Res 62 2002 1676 1681
15. A. Ristimäki, A. Sivula, and J. Lundin Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 2002 632 635
16. A. Ristimäki Cyclooxygenase 2: from inflammation to carcinogenesis Novartis Found Symp 256 2004 215 221 discussion 221-226, 259-269.
17. X. Zhao, M. Goswami, and N. Pokhriyal Cyclooxygenase-2 expression during immortalization and breast cancer progression Cancer Res 68 2008 467 475 10.1158/0008-5472.CAN-07-0782
18. J. Reader, D. Holt, and A. Fulton Prostaglandin E2 EP receptors as therapeutic targets in breast cancer Cancer Metastasis Rev 30 2011 449 463 10.1007/s10555-011-9303-2
19. C.-W. Li, W. Xia, and L. Huo Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1 Cancer Res 72 2012 1290 1300 10.1158/0008-5472.CAN-11-3123
20. D. Hanahan, and R.A. Weinberg The Hallmarks of Cancer Cell 100 2000 57 70 10.1016/S0092-8674(00)81683-9
21. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674 10.1016/j.cell.2011.02.013
22. M. Bhattacharya, K.G. Peri, and G. Almazan Nuclear localization of prostaglandin E2 receptors Proceedings of the National Academy of Sciences of the United States of America 95 1998 15792 15797
23. X. Ma, N. Kundu, and O.B. Ioffe Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities Molecular Cancer Research 8 2010 1310 1318 10.1158/1541-7786.MCR-10-0003
24. C. Han, A.J. Demetris, and D.B. Stolz Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway J Biol Chem 281 2006 24831 24846 10.1074/jbc.M602201200
25. M. Dean, A. Rzhetsky, and R. Allikmets The Human ATP-Binding Cassette (ABC) Transporter Superfamily Genome Research 11 2001 1156 1166 10.1101/gr.184901
26. R. Masereeuw, and F.G.M. Russel Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules AAPS J 14 2012 883 894 10.1208/s12248-012-9404-z
27. F.G.M. Russel, J.B. Koenderink, and R. Masereeuw Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules Trends in Pharmacological Sciences 29 2008 200 207 doi:10.1016/j.tips.2008.01.006
28. T. Huynh, M.D. Norris, and M. Haber ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma Front Oncol 2 2012 178 10.3389/fonc.2012.00178
29. J.I. Fletcher, M. Haber, and M.J. Henderson ABC transporters in cancer: more than just drug efflux pumps Nat Rev Cancer 10 2010 147 156 10.1038/nrc2789
30. A. Rasmuson, A. Kock, and O.M. Fuskevåg Autocrine Prostaglandin E2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma PLoS ONE 7 2012 e29331 10.1371/journal.pone.0029331
31. M. Montani, T. Hermanns, and T. Herrmanns Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression Virchows Arch 462 2013 437 443 10.1007/s00428-013-1390-8
32. S. Copsel, C. Garcia, and F. Diez Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation J Biol Chem 286 2011 6979 6988 10.1074/jbc.M110.166868
33. V.R. Holla, M.G. Backlund, and P. Yang Regulation of prostaglandin transporters in colorectal neoplasia Cancer Prev Res 1 2008 93 99 10.1158/1940-6207.CAPR-07-0009
34. M.J. Henderson, M. Haber, and A. Porro ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux J Natl Cancer Inst 103 2011 1236 1251 10.1093/jnci/djr256
35. G. Reid, P. Wielinga, and N. Zelcer The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs Proceedings of the National Academy of Sciences of the United States of America 100 2003 9244 9249 10.1073/pnas.1033060100
36. A. Furugen, H. Yamaguchi, and N. Tanaka Contribution of multidrug resistance-associated proteins (MRPs) to the release of prostanoids from A549 cells Prostaglandins Other Lipid Mediat 106 2013 37 44 10.1016/j.prostaglandins.2013.08.002
37. N. Abla, L.W. Chinn, and T. Nakamura The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene Journal of Pharmacology and Experimental Therapeutics 325 2008 859 868 10.1124/jpet.108.136523
38. S. Xu, J. Weerachayaphorn, and S.-Y. Cai Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression Am J Physiol Gastrointest Liver Physiol 299 2010 G126 G135 10.1152/ajpgi.00522.2010
39. L.M. Aleksunes, R.L. Yeager, and C.D. Klaassen Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers Xenobiotica 39 2009 514 522 10.1080/00498250902952514
40. I. Gori, Y. Rodriguez, and C. Pellegrini Augmented epithelial multidrug resistance-associated protein 4 expression in peritoneal endometriosis: regulation by lipoxin A(4) Fertil Steril 99 2013 1965 1973 e2. doi:10.1016/j.fertnstert.2013.01.146
41. S.M. Markova, and D.L. Kroetz ABCC4 is Regulated by microRNA-124a and microRNA-506 Biochem Pharmacol 2013 10.1016/j.bcp.2013.10.017
42. J.K. Lamba, M. Adachi, and D. Sun Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons Hum Mol Genet 12 2003 99 109
43. M.T. Hoque, G. Conseil, and S.P.C. Cole Involvement of NHERF1 in apical membrane localization of MRP4 in polarized kidney cells Biochem Biophys Res Commun 379 2009 60 64 10.1016/j.bbrc.2008.12.014
44. M. Lee, and V. Vasioukhin Cell polarity and cancer - cell and tissue polarity as a non-canonical tumor suppressor J Cell Sci 121 2008 1141 1150 10.1242/jcs.016634
45. M.T. Hoque, and S.P.C. Cole Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4 Cancer Res 68 2008 4802 4809 10.1158/0008-5472.CAN-07-0782
46. H. Hayashi, S. Naoi, and T. Nakagawa Sorting nexin 27 interacts with multidrug resistance-associated protein 4 (MRP4) and mediates internalization of MRP4 J Biol Chem 287 2012 15054 15065 10.1074/jbc.M111.337931
47. V. Gekeler, W. Ise, and K.H. Sanders The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance Biochemical And Biophysical Research Communications 208 1995 345 352
48. L. Cheung, C.L. Flemming, and F. Watt High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4) Biochem Pharmacol 2014 In Press.
49. T. Nomura, R. Lu, and M.L. Pucci The Two-Step Model of Prostaglandin Signal Termination: In Vitro Reconstitution with the Prostaglandin Transporter and Prostaglandin 15 Dehydrogenase Molecular Pharmacology 65 2004 973 978 10.1124/mol.65.4.973
50. B.S. Chan, S. Endo, and N. Kanai Identification of lactate as a driving force for prostanoid transport by prostaglandin transporter PGT Am J Physiol Renal Physiol 282 2002 F1097 F1102 10.1152/ajprenal.00151.2001
51. K. Subbaramaiah, C.A. Hudis, and A.J. Dannenberg The prostaglandin transporter regulates adipogenesis and aromatase transcription Cancer Prev Res (Phila) 4 2011 194 206 10.1158/1940-6207.CAPR-10-0367
52. K. Subbaramaiah, P.G. Morris, and X.K. Zhou Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women Cancer Discov 2 2012 356 365 10.1158/2159-8290.CD-11-0241
53. M.M. Syeda, X. Jing, and R.H. Mirza Prostaglandin transporter modulates wound healing in diabetes by regulating prostaglandin-induced angiogenesis The American Journal of Pathology 181 2012 334 346 10.1016/j.ajpath.2012.03.012
54. V.L. Schuster, Y. Chi, and Y.-T. Chang Prostaglandin transporter inhibitors 2012 US8227466 B2
55. H.J.M. Smartt, A. Greenhough, and P. Ordóñez-Morán β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin? Br J Cancer 107 2012 1514 1517 10.1038/bjc.2012.430
56. C. Pinheiro, A. Albergaria, and J. Paredes Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma Histopathology 56 2010 860 867 10.1111/j.1365-2559.2010.03560.x
57. E. Eruslanov, I. Daurkin, and J. Ortiz Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells J Leukoc Biol 88 2010 839 848 10.1189/jlb.1209821
58. I. Wolf, J. O'Kelly, and T. Rubinek 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer Cancer Research 66 2006 7818 7823 10.1158/0008-5472.CAN-05-4368
59. M. Tong, Y. Ding, and H.-H. Tai Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells Carcinogenesis 27 2006 2170 2179
60. M. Yan, S.J. Myung, and S.P. Fink 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors Proceedings of the National Academy of Sciences 2009 9409 106
61. L. Lu, K. Byrnes, and C. Han miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth Mol Cancer Res 2014 In Press.
62. H.-H. Tai Prostaglandin catabolic enzymes as tumor suppressors Cancer Metastasis Rev 30 2011 409 417 10.1007/s10555-011-9314-z
63. X. Chi, B.M. Freeman, and M. Tong 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells Arch Biochem Biophys 487 2009 139 145 10.1016/j.abb.2009.05.017
64. H.-H. Tai, X. Chi, and M. Tong Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs) Prostaglandins Other Lipid Mediat 96 2011 37 40 10.1016/j.prostaglandins.2011.06.005
65. D.G. Menter, R.L. Schilsky, and R.N. DuBois Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward Clinical Cancer Research 16 2010 1384 1390 10.1158/1078-0432.CCR-09-0788